Paper28533249
The Myxobacterial Metabolite Soraphen A Inhibits HIV-1 by Reducing Virus Production and Altering Virion Composition.
Fleta-Soriano E and 11 others. Antimicrob Agents Chemother, 2017. Cited by 7 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Myxobacterial Metabolite Soraphen A Inhibits HIV-1 by Reducing Virus Production and Altering Virion Composition. Papers, record 28533249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28533249
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Myxobacterial Metabolite Soraphen A Inhibits HIV-1 by Reducing Virus Production and Altering Virion Composition.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-HIV Agents | Major topic |
| HIV Infections | Major topic |
| HIV-1 | Major topic |
| Macrolides | Major topic |
| Virus Internalization | Major topic |
| Virus Replication | Major topic |
| Acetyl-CoA Carboxylase | |
| Cell Line, Tumor | |
| HIV Envelope Protein gp120 | |
| Humans | |
| Hydroxamic Acids | |
| Lipoylation | |
| Myxococcales | |
| Palmitic Acid | |
| Vorinostat |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11038187 | Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. | J Cell Biol | 2000 | https://conductscience.org/library/papers/11038187 | PubMed |
| 2 | 23112332 | Maturation-dependent HIV-1 surface protein redistribution revealed by fluorescence nanoscopy. | Science | 2012 | https://conductscience.org/library/papers/23112332 | PubMed |
| 3 | 11095714 | Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/11095714 | PubMed |
| 4 | 15113929 | Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles. | J Virol | 2004 | https://conductscience.org/library/papers/15113929 | PubMed |
| 5 | 8389472 | Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8389472 | PubMed |
| 6 | 21530270 | Multifaceted roles for lipids in viral infection. | Trends Microbiol | 2011 | https://conductscience.org/library/papers/21530270 | PubMed |
| 7 | 18432938 | Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays. | Curr Protoc Immunol | 2005 | https://conductscience.org/library/papers/18432938 | PubMed |
| 8 | 19937746 | Optimized time-gated generalized polarization imaging of Laurdan and di-4-ANEPPDHQ for membrane order image contrast enhancement. | Microsc Res Tech | 2010 | https://conductscience.org/library/papers/19937746 | PubMed |
| 9 | 19309310 | Triton X-100 promotes a cholesterol-dependent condensation of the plasma membrane. | Biochem J | 2009 | https://conductscience.org/library/papers/19309310 | PubMed |
| 10 | 24063434 | Identification of myxobacteria-derived HIV inhibitors by a high-throughput two-step infectivity assay. | Microb Cell Fact | 2013 | https://conductscience.org/library/papers/24063434 | PubMed |
| 11 | 6199166 | Filipin as a flow microfluorometry probe for cellular cholesterol. | Cytometry | 1984 | https://conductscience.org/library/papers/6199166 | PubMed |
| 12 | 7568235 | The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7568235 | PubMed |
| 13 | 18820684 | Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. | Nat Biotechnol | 2008 | https://conductscience.org/library/papers/18820684 | PubMed |
| 14 | 23486665 | Inhibition of rotavirus replication by downregulation of fatty acid synthesis. | J Gen Virol | 2013 | https://conductscience.org/library/papers/23486665 | PubMed |
| 15 | 15956582 | Wild-type-like viral replication potential of human immunodeficiency virus type 1 envelope mutants lacking palmitoylation signals. | J Virol | 2005 | https://conductscience.org/library/papers/15956582 | PubMed |
| 16 | 27990142 | Homeostatically Maintained Resting Naive CD4+ T Cells Resist Latent HIV Reactivation. | Front Microbiol | 2016 | https://conductscience.org/library/papers/27990142 | PubMed |
| 17 | 21497090 | Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility. | Curr Biol | 2011 | https://conductscience.org/library/papers/21497090 | PubMed |
| 18 | 26348152 | An optimized method for high-titer lentivirus preparations without ultracentrifugation. | Sci Rep | 2015 | https://conductscience.org/library/papers/26348152 | PubMed |
| 19 | 15661172 | Effects of virion surface gp120 density on infection by HIV-1 and viral production by infected cells. | Virology | 2005 | https://conductscience.org/library/papers/15661172 | PubMed |
| 20 | 23705972 | The frantic play of the concealed HIV envelope cytoplasmic tail. | Retrovirology | 2013 | https://conductscience.org/library/papers/23705972 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35031766 | Lipogenesis inhibitors: therapeutic opportunities and challenges. | Nat Rev Drug Discov | 2022 | https://conductscience.org/library/papers/35031766 | PubMed |
| 34661071 | Physiologically Based Pharmacokinetic/Pharmacodynamic Model for the Treatment of Dengue Infections Applied to the Broad Spectrum Antiviral Soraphen A. | ACS Pharmacol Transl Sci | 2021 | https://conductscience.org/library/papers/34661071 | PubMed |
| 34452226 | Myxobacteria as a Source of New Bioactive Compounds: A Perspective Study. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34452226 | PubMed |
| 30999821 | Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models. | Emerg Microbes Infect | 2019 | https://conductscience.org/library/papers/30999821 | PubMed |
| 30597184 | Third Tofo Advanced Study Week on Emerging and Re-emerging Viruses, 2018. | Antiviral Res | 2019 | https://conductscience.org/library/papers/30597184 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ITIH4 | 3700 | PubTator's text mining | https://conductscience.org/library/genes/3700 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28533249
GET https://conductscience.org/api/papers/v1/28533249/references?page=2